{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-009679","form_type":"8-K","ticker":"OKUR","cik":"0001637715","company_name":"OnKure Therapeutics, Inc.","filed_at":"2022-06-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.582286+00:00","generated_at":"2026-06-25T05:09:33.898109+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Reneo shareholders elect Dube and Hoelscher as Class I directors, ratify Ernst & Young as auditor","bullets":["Annual Meeting held June 1, 2022; total outstanding shares 24,458,550.","Eric M. Dube elected with 18,100,489 votes for, 795,195 against, 2,790,889 broker non-votes.","Paul W. Hoelscher elected with 18,877,021 votes for, 18,663 against, 2,790,889 broker non-votes.","Ratification of Ernst & Young as independent auditor for fiscal 2022 approved (21,675,242 for, 11,300 against)."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-009679","json":"https://secwatch.observer/filing/0001558370-22-009679.json","markdown":"https://secwatch.observer/filing/0001558370-22-009679.md","text":"https://secwatch.observer/filing/0001558370-22-009679.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1637715/000155837022009679/0001558370-22-009679-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1637715/000155837022009679/rphm-20220601x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T05:09:33.898109+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}